Update Alert 5: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults

Ann Intern Med. 2020 Dec 15;173(12):167-168. doi: 10.7326/L20-1293. Epub 2020 Oct 27.

Authors

Katherine Mackey¹, Devan Kansagara¹, Kathryn Vela¹

Affiliation

¹ VA Portland Health Care System, Portland, Oregon (K.M., D.K., K.V.).

No abstract available

Publication types

Letter
Comment

MeSH terms

Adult
Angiotensin Receptor Antagonists* / adverse effects
Angiotensin-Converting Enzyme Inhibitors / adverse effects
Angiotensins
COVID-19*
Humans
Renin-Angiotensin System
SARS-CoV-2

Substances

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Angiotensins